Antengene
Highly Engaged Employees

Q: What is Antengene's official website?

Antengene's official website is www.antengene.com

Q: What is Antengene's Revenue?

Antengene's revenue is <$5 Million

Q: How many employees does Antengene have?

Antengene has 201-500 employees

Q: What industry does Antengene belong to?

Antengene is in the industry of: Manufacturing , Pharmaceuticals , Business Services

Q: What technology does Antengene use?

Some of the popular technologies that Antengene uses are: WordPress.org, TriNet, DigiCert, Vue

Q: How do I contact Antengene?

Antengene contact info: Phone number: +86 1050951066 Website: www.antengene.com

Q: What does Antengene do?

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on innovative first-in-class/best-in-class therapeutic medicines for cancer and other life-threatening diseases. Driven by its vision of "Treating Patients Beyond Borders", Antengene aims to provide the most a... dvanced anti-cancer drugs to patients in the Asia Pacific Region and around the world. Since initiating operations in 2017, Antengene has obtained 23 investigational new drug (IND) approvals in the US and in Asia, submitted 6 new drug applications (NDAs) in multiple Asia Pacific markets, with the NDA for XPOVIO® (selinexor) in China, South Korea, Singapore and Australia approved. Leveraging partnerships as well as in-house drug discovery, Antengene has built a broad and expanding pipeline of 15 clinical and pre-clinical assets. Antengene has global rights on 10 programs and Asia Pacific rights, including the Greater China region, on 5 programs. Read More

Q: Who invested in Antengene?

Antengene has 10 investors including Qiming Venture Partners, Huagai Capital, TF Capital and Tigermed.

Q: Is Antengene a public company?

Antengene is private company therefore does not currently have an official ticker symbol

Manufacturing · China · 201-500 Employees

View Company Info for Free

Overview

Headquarters

Soho Plaza 1065 W Zhongshan Road Suites ...

Phone Number

+86 1050951066

Website

www.antengene.com

Revenue

<$5 Million

Industry

Manufacturing

Pharmaceuticals

Business Services

Research & Development

About Antengene

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on innovative first-in-class/best-in-class therapeutic medicines for cancer and other life-threatening diseases. Driven by its vision of "Treating Patients Beyond Borders", Antengene aims to provide the most advanced anti-cancer drugs to patients in the Asia Pacific Region and around the world. Since initiating operations in 2017, Antengene has obtained 23 investigational new drug (IND) approvals in the US and in Asia, submitted 6 new drug applications (NDAs) in multiple Asia Pacific markets, with the NDA for XPOVIO® (selinexor) in China, South Korea, Singapore and Australia approved. Leveraging partnerships as well as in-house drug discovery, Antengene has built a broad and expanding pipeline of 15 clinical and pre-clinical assets. Antengene has global rights on 10 programs and Asia Pacific rights, including the Greater China region, on 5 programRead more